Engineered yeast uses NtEAH, bisabolol synthase, and P450 reductase to raise hernandulcin yield and purity for scalable production.
A T-to-G change in the lactate dehydrogenase promoter cuts lactic acid while boosting L-glutamic acid production in Corynebacterium.
Engineered plasmids raise miRNA levels in target cells to degrade or inactivate mRNA, lowering harmful biomolecule expression and restoring homeostasis.
Specific amino acid substitutions improve carbonyl reductase thermal stability and stereoselectivity, cutting enzyme use in chiral compound production.
Variant KAH enzymes improve kaurenoic acid to steviol conversion in yeast, enabling higher-yield production of Reb M and related steviol glycosides.
Mapped oxidation and glycosylation enzymes reconstruct the quillaic acid pathway, enabling scalable triterpenoid saponin production in host cells.
A surface-linker-enzyme reactor cell enables controlled electron transfer, simplifying formate or formic acid production.
Targeted ketoreductase mutations improve stereoselective 3-ketothiolane reduction while maintaining activity, thermostability, and solvent stability.
Direct enzyme-to-electrode linking simplifies bioelectrocatalysis and improves control of hydrogen peroxide production.
A one-pot plasma biocatalysis setup uses porous enzyme immobilization to preserve activity while boosting reactive species and yield.
An ODD-family enzyme hydroxylates flavanones at the 2-position, supporting 2-hydroxyflavanone production and blue-flower modification.
Variant UGT76G1 enzymes improve Reb D-to-Reb M conversion in engineered yeast, addressing low wild-type efficiency and productivity.
P146 and N275 substitutions target low soluble yield and instability in recombinant HRP production in E. coli.